Inhaled Anti-Inflammatory Agent
APT is studying a nebulized formulation of an approved oral drug. It could have significant utility treating troublesome inflammation in patients with cycstic fibrosis, chronic obstructive pulmonary disease, bronchiectasis and lung transplant. |
